Alexza Pharmaceuticals (ALXA) +4.2% premarket after receiving a compliance certificate for its...

|About: Alexza Pharmaceuticals, Inc. (ALXA)|By:, SA News Editor

Alexza Pharmaceuticals (ALXA) +4.2% premarket after receiving a compliance certificate for its Adasuve manufacturing facility from the EU. Adasuve, a schizophrenic and bipolar disorder treatment, is ALXA's lone product candidate.